Literature DB >> 6251260

Alterations in glycoprotein gB specified by mutants and their partial revertants in herpes simplex virus type 1 and relationship to other mutant phenotypes.

M L Haffey, P G Spear.   

Abstract

The tsB5 mutant of herpes simplex virus type 1 (HSV-1) strain HFEM was shown previously to be temperature sensitive for accumulation of the mature form of glycoprotein gB, for production or activity of a factor required in virus-induced cell fusion, and for production of virions with normal levels of infectivity. In addition, a previous study showed that virions produced by tsB5 at permissive temperature were more thermolabile than HFEM virions and contained altered gB that did not assume the dimeric conformation characteristic of HFEM. Results presented here demonstrate that, at permissive temperature, tsB5 differs from HFEM in another respect: plaques formed by tsB5 are syncytial on Vero cells (but not on HEp-2 cells), whereas plaques formed by HFEM are nonsyncytial on both cell types. In addition, our results indicate that tsB5 produces an oligomeric form of gB, but that it differs in electrophoretic mobility and stability from the gB dimers of HFEM. The major purpose of this study was to investigate the dependence of the various tsB5 mutant phenotypes on the temperature sensitivity of gB accumulation and on the alterations in oligomeric conformation of gB produced at permissive temperature. For this work the following HSV-1 strains related to tsB5 or HFEM were analyzed: (i) phenotypic revertants selected from tsB5 stocks for nonsyncytial plaque morphology on Vero cells or for ability to form plaques at restrictive temperature (38.5 degrees C); (ii) a plaque morphology variant of HFEM selected for its syncytial phenotype on Vero cells; (iii) temperature-sensitive recombinants previously isolated from a cross between tsB5 and the non-temperature-sensitive syncytial strain HSV-1(MP); and (iv) a phenotypic revertant selected from one of the recombinant stocks for its ability to form plaques at 39 degrees C. These strains were all compared with tsB5 and HFEM at three different temperatures in two different cell lines with respect to plaque formation, yield of infectious progeny, virus-induced cell fusion, and accumulation of gB. The results of our analyses on all the strains tested revealed the following correlations between mutant phenotypes and the accumulation and oligomeric conformation of gB. (i) There was a direct and quantitative relationship between the accumulation in infected cells of infectious progeny and of the mature form of gB, providing strong support for the hypothesis that this form of gB is necessary to the production of infectious virions. The oligomeric conformation of gB characteristic of HFEM is apparently not required for virion infectivity; nor was virion thermostability necessarily related to the presence of the HFEM-like oligomeric form of gB. (ii) The previously reported correlation between temperature sensitivity of gB accumulation and virus-induced cell fusion was confirmed for tsB5 and extended to other virus strains, and coordinate reversion of these traits was also demonstrated, providing support for the hypothesis that gB has a role in virus-induced cell fusion. At 37 degrees C, intermediate between permissive and restrictive temperatures, some of the mutants and partial revertants induced cell fusion despite reduced accumulations of the mature form of gB, suggesting that the amount of mature gB present did not determine the extent of fusion and that other forms of gB as well as other factors should be investigated with regard to the process of cell fusion. (iii) Some of the mutants and partial revertants could form plaques at 38.5 degrees C despite reduced accumulations of gB and infectious progeny, indicating that the cell-to-cell transmission of viral infection may be at least in part independent of these factors.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6251260      PMCID: PMC288787     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  22 in total

1.  Polykaryocytosis.

Authors:  B ROIZMAN
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1962

2.  Membrane proteins specified by herpes simplex viruses. III. Role of glycoprotein VP7(B2) in virion infectivity.

Authors:  M Sarmiento; M Haffey; P G Spear
Journal:  J Virol       Date:  1979-03       Impact factor: 5.103

3.  Membrane proteins specified by herpes simplex viruses. IV. Conformation of the virion glycoprotein designated VP7(B2).

Authors:  M Sarmiento; P G Spear
Journal:  J Virol       Date:  1979-03       Impact factor: 5.103

4.  Membrane proteins specified by herpes simplex viruses. V. Identification of an Fc-binding glycoprotein.

Authors:  R B Baucke; P G Spear
Journal:  J Virol       Date:  1979-12       Impact factor: 5.103

5.  Collaborative complementation study of temperature-sensitive mutants of herpes simplex virus types 1 and 2.

Authors:  P A Schaffer; V C Carter; M C Timbury
Journal:  J Virol       Date:  1978-09       Impact factor: 5.103

6.  Surface glycopeptides in the envelope of herpes simplex virions.

Authors:  U Olshevsky; Y Becker
Journal:  Virology       Date:  1972-10       Impact factor: 3.616

7.  Characterization of herpes simplex virus strains differing in their effects on social behaviour of infected cells.

Authors:  P M Ejercito; E D Kieff; B Roizman
Journal:  J Gen Virol       Date:  1968-05       Impact factor: 3.891

8.  A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels.

Authors:  W M Bonner; R A Laskey
Journal:  Eur J Biochem       Date:  1974-07-01

9.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

10.  Proteins specified by herpes simplex virus. XIII. Glycosylation of viral polypeptides.

Authors:  R W Honess; B Roizman
Journal:  J Virol       Date:  1975-11       Impact factor: 5.103

View more
  21 in total

1.  Identification of a site on herpes simplex virus type 1 glycoprotein D that is essential for infectivity.

Authors:  M I Muggeridge; W C Wilcox; G H Cohen; R J Eisenberg
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

2.  Antigenic variation (mar mutations) in herpes simplex virus glycoprotein B can induce temperature-dependent alterations in gB processing and virus production.

Authors:  S D Marlin; S L Highlander; T C Holland; M Levine; J C Glorioso
Journal:  J Virol       Date:  1986-07       Impact factor: 5.103

3.  Identification of a herpes simplex virus 1 glycoprotein gene within a gene cluster dispensable for growth in cell culture.

Authors:  R Longnecker; S Chatterjee; R J Whitley; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

4.  Anatomy of the herpes simplex virus 1 strain F glycoprotein B gene: primary sequence and predicted protein structure of the wild type and of monoclonal antibody-resistant mutants.

Authors:  P E Pellett; K G Kousoulas; L Pereira; B Roizman
Journal:  J Virol       Date:  1985-01       Impact factor: 5.103

5.  Kinetics of expression of herpes simplex virus type 1-specific glycoprotein species on the surfaces of infected murine, simian, and human cells: flow cytometric analysis.

Authors:  S R Jennings; P A Lippe; K J Pauza; P G Spear; L Pereira; S S Tevethia
Journal:  J Virol       Date:  1987-01       Impact factor: 5.103

6.  Disulfide bonds of herpes simplex virus type 2 glycoprotein gB.

Authors:  N Norais; D Tang; S Kaur; S H Chamberlain; F R Masiarz; R L Burke; F Marcus
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

7.  Characterization of a herpes simplex virus type 1 mutant resistant to benzhydrazone, a selective inhibitor of herpesvirus glycosylation.

Authors:  M Tognon; R Manservigi; V Cavrini; G Campadelli-Fiume
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

8.  Endo-beta-N-acetylglucosaminidase H sensitivity of precursors to herpes simplex virus type 1 glycoproteins gB and gC.

Authors:  E A Wenske; M W Bratton; R J Courtney
Journal:  J Virol       Date:  1982-10       Impact factor: 5.103

9.  Infectivity and glycoprotein processing of herpes simplex virus type 1 grown in a ricin-resistant cell line deficient in N-acetylglucosaminyl transferase I.

Authors:  G Campadelli-Fiume; L Poletti; F Dall'Olio; F Serafini-Cessi
Journal:  J Virol       Date:  1982-09       Impact factor: 5.103

10.  Multimeric forms of herpes simplex virus type 2 glycoproteins.

Authors:  R Eberle; R J Courtney
Journal:  J Virol       Date:  1982-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.